Premium
Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership
Author(s) -
Dive C,
Shishido SN,
Kuhn P
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.657
Subject(s) - general partnership , cancer , liquid biopsy , circulating tumor cell , medicine , oncology , medical physics , political science , metastasis , law
The Kuhn Laboratory at the University of Southern California and the Dive Laboratory at the Cancer Research UK's Manchester Institute are teaming up to apply new cancer cell detection technology to identify patients who will progress after initial treatment. Researchers will take a simple blood sample to identify early those patients whose cancer has returned, while analyzing circulating tumor cells (CTCs) in great detail, providing new clues on the most effective therapy for the patient's cancer.